Thank you, Eilif. As a reminder, campus-based higher education is a seasonal business. The third quarter represents the primary intake cycle for Mexico, a Northern Hemisphere market, and a smaller secondary intake cycle for Peru, which is a Southern Hemisphere market. Although, the third quarter is a large intake period from a P&L perspective, it is seasonally low, as classes are out of session for much of the quarter. Let's start with page 12, which highlights our strong operating and financial performance for the third quarter. New enrollments increased 14% and total enrollments were up 10% when compared to the prior year period. Revenue in the third quarter was $301 million and adjusted EBITDA was $73 million. Both metrics were ahead of the guidance we provided three months ago. Revenue outperformance was driven by new enrollment results, which exceeded expectations for the recent intake cycle. Adjusted EBITDA outperformance followed the revenue trend and was aided by the shifting of some expenses to the fourth quarter of the year. On an organic constant currency basis, revenue for the third quarter was up 11% year-over-year, driven by the growth in total enrollment volume. Adjusted EBITDA for the third quarter was down 8% year-over-year as expected and as we had previously guided. This was due to return to campus expenses in a largely out-of-session quarter, as well as certain timing items. When combined with the first half on an organic constant currency basis, our overall year-to-date performance through September resulted in year-over-year revenue and adjusted EBITDA growth of 13% and 17% respectively. Let me now provide some additional color on the performance of Mexico and Peru, starting with page 15. Please note that, all comparisons versus prior year are on an organic and constant currency basis. Let's start with Mexico. Mexico just completed its primary intake for the year and the results were very strong. New enrollments increased 17%, during the third quarter when compared to the same period last year. We experienced double-digit, new enrollment growth in both our premium brand at UVM and our value brand at UNITEC. Across product lines, we saw double-digit increases in our face-to-face and hybrid offerings as most students have now returned to presential studies and we continue to experience growth in fully online. Mexico's revenue for the third quarter, increased 14% compared to the prior year period and 10% when adjusted for academic calendar timing. The strong September intake will be fully realized in Mexico's revenue growth, during the fourth quarter. Adjusted EBITDA for the third quarter was down 11% year-over-year, as anticipated and guided due to return to campus expenses incurred during a largely out-of-session quarter and certain timing items. On a year-to-date basis, revenue in Mexico increased 12% compared to the prior year period and adjusted EBITDA was up 8%. Let's now transition to Peru, on Slide 16. We continue to have strong performance in Peru. New enrollment during Peru's secondary intake was up 8% in the third quarter compared to the prior year period. On a year-to-date basis, including the primary intake completed in the first quarter, new enrollment increased 7% year-over-year. Volume growth and favorable price/mix drove a 10% year-over-year increase in constant currency revenue for the third quarter or 12% when adjusted for the academic calendar timing. Adjusted EBITDA for the third quarter, decreased 18% year-over-year as anticipated and guided due to return to campus expenses, and certain timing items during a low seasonal quarter. On a year-to-date basis, revenue in Peru increased 15% over the prior year period. Year-over-year revenue growth for the first nine months of 2022 was aided by the high level of returning students in the second half of 2021, related to the COVID recovery. This benefit has now lapped a full year impact. And going forward, we expect revenue growth in Peru to be more in line with our top line growth targets. On a year-to-date basis, adjusted EBITDA was flat with prior year with revenue flow-through partially offset by additional costs, incurred this year as we return to campus operations in Peru. Let me now, briefly discuss our balance sheet illustrated on Page 17, of the earnings presentation. The third quarter is a seasonally high cash flow period for Laureate. Strong free cash flow generation of $100 million in the third quarter, combined with the collection of the final escrow payment related to the sale of Walden, resulted in a net cash position of $192 million as of September 30. As Eilif noted in his opening remarks, we distributed $137 million of that cash to investors in October through a special cash distribution and we will distribute another $112 million to investors on November 17 via a special cash dividend, which was declared on October 24. Now let's move on to our updated outlook for 2022, on Page 19. On the strength of Laureate's third quarter intake cycles, we are increasing our 2022 full year outlook at the midpoint by 6,000 students, $15 million for revenue and $1 million for adjusted EBITDA. The increase in our adjusted EBITDA guidance does not fully reflect flow-through margins on incremental revenue for two reasons. First, we are taking the opportunity to reinvest some of our revenue outperformance in the fourth quarter to set us up for a more favorable 2023 outlook. This includes investments in digital initiatives and the acceleration of efficiency projects. Second, we have some additional onetime costs associated with the corporate wind down that are impacting us in the second half of this year. This is resulting in a slightly slower ramp down, in corporate costs versus initial expectations. However, we are still on track to achieve the corporate rightsizing previously discussed with investors, and you will see that reflected in our guidance for 2023, which will be provided in February. Based on current spot FX rates, our updated guidance for the full year 2022 is as follows: total enrollment to be in the range of 420,000 to 423,000 students reflecting growth of 9%, on an organic basis versus 2021; revenue to be in the range of $1.223 billion to $1.231 billion reflecting growth of 12% on an organic constant currency basis and 13%, on a reported basis versus 2021; and adjusted EBITDA to be in the range of $331 million to $337 million, reflecting growth of 23% to 25% on an organic constant currency basis versus 2021, or an increase of 31% to 33% on a reported basis, which includes the effect of the noncash FAS five charge in 2021. Eilif, I'm handing it back to you for closing comments.